BARX1

Across TCGA pan-cancer cohorts, BARX1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated BARX1 data layer compared with 30 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher BARX1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated BARX1 expression acts as an unfavorable survival marker.

COAD, STAD, and SKCM are the cancer types where BARX1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.125	0.799	<.001	22	view →
STAD	OS	Median	II,III,IV	0.183	0.677	.004	21	view →
SKCM	DFS	Median	All	0.130	0.737	.003	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

BARX1–COAD (OS)

Open the COAD breakdown →